A

ALK-Abelló
ALK B

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
DKK40.48B
EV
DKK40.76B
Shares Outstanding
221.49M
Beta
0.63

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
DKK179.75
P/E 2025E
35.45x
P/Revenue 2025E
6.53x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ALK-Abelló A/S

gainify

A

ALK-Abelló A/S

ALK B

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and...

Sector

Healthcare

Industry

Biotechnology

CEO

Halling, Peter

Employees

2,736

IPO Date

2000-03-10

Headquarters

BOege AllE 6-8, Horsholm, Capital Region of Denmark, 2970, Denmark

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.